Source: Annual Congress 2005 - Clinical issues before and after lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. López García-Gallo, P. Ussetti, R. Laporta, M. C. Carreno, A. de Pablo, M. Ferreiro (Madrid, Spain). Is gammaglobuline anti-CMV warranted in lung transplantation?. Eur Respir J 2005; 26: Suppl. 49, 4040

Member's Comments

No comment yet.

Related content which might interest you: Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 Long-term follow-up after lung transplantation – impact of A1-rejection? Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Current outcome after lung transplantation Source: Annual Congress 2012 - Lung transplantation in 2012: where are we? Year: 2012 Rapid decline in lung disease other than COPD: when should lung transplantation be considered? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007 Pre-habilitation in lung transplant candidates Source: Short video discussion 2021 Year: 2021 Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 Indications for lung transplantation: from ideal recipients to challenging candidates Source: International Congress 2019 – Lung transplantation in 2019: where are we? Year: 2019 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 Safety of antifibrotic drugs in idiopathic pulmonary fibrosis patients awaiting lung transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Is preoperative pulmonary evaluation necessary in renal transplant patients? Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Pulmonary viral infection in hematologic patients with and without stemcell transplantation Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Benefit of pulmonary rehabilitation in candidates for lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Selection of emphysema patients for lung transplantation today Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016